These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

943 related articles for article (PubMed ID: 27730513)

  • 21. Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist exendin-4.
    Lietzau G; Nyström T; Östenson CG; Darsalia V; Patrone C
    Oncotarget; 2016 Feb; 7(5):5865-76. PubMed ID: 26744321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer's disease.
    Vandal M; White PJ; Chevrier G; Tremblay C; St-Amour I; Planel E; Marette A; Calon F
    FASEB J; 2015 Oct; 29(10):4273-84. PubMed ID: 26108977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain Insulin Signaling Is Increased in Insulin-Resistant States and Decreases in FOXOs and PGC-1α and Increases in Aβ1-40/42 and Phospho-Tau May Abet Alzheimer Development.
    Sajan M; Hansen B; Ivey R; Sajan J; Ari C; Song S; Braun U; Leitges M; Farese-Higgs M; Farese RV
    Diabetes; 2016 Jul; 65(7):1892-903. PubMed ID: 26895791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.
    Lester-Coll N; Rivera EJ; Soscia SJ; Doiron K; Wands JR; de la Monte SM
    J Alzheimers Dis; 2006 Mar; 9(1):13-33. PubMed ID: 16627931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice.
    Chua LM; Lim ML; Chong PR; Hu ZP; Cheung NS; Wong BS
    J Alzheimers Dis; 2012; 29(4):783-91. PubMed ID: 22337827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Involvement of Insulin-Like Growth Factor 1 and Nerve Growth Factor in Alzheimer's Disease-Like Pathology and Survival Role of the Mix of Embryonic Proteoglycans: Electrophysiological Fingerprint, Structural Changes and Regulatory Effects on Neurotrophins.
    Aghajanov M; Matinyan S; Chavushyan V; Danielyan M; Karapetyan G; Mirumyan M; Fereshetyan K; Harutyunyan H; Yenkoyan K
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease.
    Siddiqui N; Ali J; Parvez S; Zameer S; Najmi AK; Akhtar M
    Neuropharmacology; 2021 Sep; 195():108662. PubMed ID: 34119519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
    Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
    J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interplay between Alzheimer's disease and global glucose metabolism revealed by the metabolic profile alterations of pancreatic tissue and serum in APP/PS1 transgenic mice.
    Liu X; Wang W; Chen HL; Zhang HY; Zhang NX
    Acta Pharmacol Sin; 2019 Oct; 40(10):1259-1268. PubMed ID: 31089202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes.
    Yang Y; Ma D; Wang Y; Jiang T; Hu S; Zhang M; Yu X; Gong CX
    J Alzheimers Dis; 2013; 33(2):329-38. PubMed ID: 22936005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central insulin and insulin-like growth factor-1 signaling: implications for diabetes associated dementia.
    Zemva J; Schubert M
    Curr Diabetes Rev; 2011 Sep; 7(5):356-66. PubMed ID: 21916834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models.
    Kimura N
    Int J Mol Sci; 2016 Apr; 17(4):503. PubMed ID: 27058526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers.
    Carvalho C; Santos MS; Oliveira CR; Moreira PI
    Biochim Biophys Acta; 2015 Aug; 1852(8):1665-75. PubMed ID: 25960150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
    Steen E; Terry BM; Rivera EJ; Cannon JL; Neely TR; Tavares R; Xu XJ; Wands JR; de la Monte SM
    J Alzheimers Dis; 2005 Feb; 7(1):63-80. PubMed ID: 15750215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Klotho upregulation contributes to the neuroprotection of ligustilide in an Alzheimer's disease mouse model.
    Kuang X; Chen YS; Wang LF; Li YJ; Liu K; Zhang MX; Li LJ; Chen C; He Q; Wang Y; Du JR
    Neurobiol Aging; 2014 Jan; 35(1):169-78. PubMed ID: 23973442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus.
    Moroz N; Tong M; Longato L; Xu H; de la Monte SM
    J Alzheimers Dis; 2008 Sep; 15(1):29-44. PubMed ID: 18780965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.